Lupin informs about press release

25 Mar 2019 Evaluate

Lupin has informed about submission of a press release titled, ‘Lupin receives FDA approval for Sildenafil Tablets USP’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2082.60 27.55 (1.34%)
11-Dec-2025 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.45
Dr. Reddys Lab 1271.80
Cipla 1510.10
Zydus Lifesciences 924.75
Lupin 2082.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×